|
Volumn 91, Issue 3, 2012, Pages 383-385
|
Current and future state of FDA-CMS parallel reviews
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DECISION MAKING;
DRUG EFFICACY;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE COST;
MEDICAID;
MEDICARE;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PRODUCT DEVELOPMENT;
REIMBURSEMENT;
REVIEW;
CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.);
CONSUMER PRODUCT SAFETY;
DRUG APPROVAL;
DRUG INDUSTRY;
FORECASTING;
HEALTH CARE SECTOR;
HUMANS;
INSURANCE COVERAGE;
LEGISLATION, DRUG;
MEDICARE;
PHARMACEUTICAL PREPARATIONS;
PROFESSIONAL REVIEW ORGANIZATIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84857200092
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2011.350 Document Type: Review |
Times cited : (14)
|
References (5)
|